Differential effects of specific antipsychotic drugs on metabolic markers and diabetes: A register-based study on 4,909 patients with schizophrenia

INTRODUCTION: Antipsychotics (AP) are used as the primary pharmaceutical treatment for schizophrenia. Randomised clinical trials (RCT) show that the initiation of AP treatment often induces side effects such as substantial weight gain and metabolic disturbances, including an increased risk of type-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Sørensen, M. A., Köhler-Forsberg, O., Rohde, C. G., Danielsen, A. A., Mors, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479105/
http://dx.doi.org/10.1192/j.eurpsy.2023.2270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479105/
http://dx.doi.org/10.1192/j.eurpsy.2023.2270

Ejemplares similares